3Masubuchi Y, Bourdi M, Reilly TP, et al . Role of interleukin--6 in hepatic heat shock protein expression and protection against acetaminophen- induced liver disease. Biochem Biophys Res Commun, 2003, 304(1):207-212
10Hussain Z, Kar P, Husain SA. Antituberculosis drug induced hepatitis: risk factors, prevention and management.Indian J Exp Biol,2003, 41(11) : 26-32
二级参考文献28
1陈灏珠.实用内科学(第11版)[M].北京:人民卫生出版社,2002 4.958.
2Sasseville VG, Lane JH, Kadambi VJ, et al. Testing paradigm for prediction of development-limiting barriers and human drug toxicity [J]. Chem Biol Interact, 2004, 150(1):9- 25.
3Lee WM. Drug induced hepatotoxicity[J]. N Engl J Med, 2003,349(5) :474 - 485.
4Xu JJ, Diaz D, O'Brien PJ. Application of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential[J]. Chem Biol Interact, 2004, 150(1) :115 - 128.
5Shenton JM, Chen J, Uetrecht JP. Animal models of idiosyncratic drug reaction[J]. Chem Biol Interact, 2004, 150(1) :53 - 70.
6Gao J, Garulacan LA, Storm SM, et al. Biomarker discovery in biological fluids[J]. Methods, 2005, 35(3) :291 - 302.
7Liguori MJ, Anderson LM, Bukofzer S, et al. Microarray analysisin human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin [ J ]. Hepatology, 2005, 41 ( 1 ): 177 - 186.
8Harrigan GG, LaPlante RH, Cosma GN, et al. Application of highthroughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity[J]. Toxicol Lett, 2004, 146(3): 197 - 205.
9Snodin DT. Toxicology and adverse Drug Reactions[ A]. In: Talbot J, Waller B, eds. Stephen's detection of new adverse drug reaction [M]. 5th ed. Chichester West Sussex: John Wiley & Sons. Ltd,2004:127 - 166.
10Li AP. Accurate prediction of human drug toxicity: a major challenge in drug development[J]. Chem Biol Interact, 2004, 150(1):3- 7.
